The global Biological Safety and Biocompatibility Testing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Endotoxin Test Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Biological Safety and Biocompatibility Testing include Charles River Laboratories, Lonza, Thermo Fisher Scientific, Merck KGaA, F. Hoffmann-La Roche, Agilent Technologies, Labcorp, SGS SA and WuXi AppTec, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Safety testing?includes a set of assays used to test preclinical and clinical vector product lots prior to use in animals or humans.
This report aims to provide a comprehensive presentation of the global market for Biological Safety and Biocompatibility Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Safety and Biocompatibility Testing. This report contains market size and forecasts of Biological Safety and Biocompatibility Testing in global, including the following market information:
- Global Biological Safety and Biocompatibility Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Biological Safety and Biocompatibility Testing Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Biological Safety and Biocompatibility Testing companies in 2023 (%)
We surveyed the Biological Safety and Biocompatibility Testing manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biological Safety and Biocompatibility Testing Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Biological Safety and Biocompatibility Testing Market Segment Percentages, by Type, 2023 (%)
- Endotoxin Test
- Sterility Test
- Mycoplasma Test
- Bioburden Test
- Residual Host-cell Proteins & DNA Detection Tests
- Virus safety Test
- Other
Global Biological Safety and Biocompatibility Testing Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Biological Safety and Biocompatibility Testing Market Segment Percentages, by Application, 2023 (%)
- Vaccine
- Monoclonal Antibodies
- Cellular & Gene Therapy Products
- Blood and Blood Products
- Other
Global Biological Safety and Biocompatibility Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Biological Safety and Biocompatibility Testing Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biological Safety and Biocompatibility Testing revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Biological Safety and Biocompatibility Testing revenues share in global market, 2023 (%)
- Key companies Biological Safety and Biocompatibility Testing sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Biological Safety and Biocompatibility Testing sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Charles River Laboratories
- Lonza
- Thermo Fisher Scientific
- Merck KGaA
- F. Hoffmann-La Roche
- Agilent Technologies
- Labcorp
- SGS SA
- WuXi AppTec
- Sartorius AG
- Associates of Cape Cod
- bioM?rieux SA
- Eurofins Scientific
- FUJIFILM
- Almac Group
- Bio-Rad Laboratories
- QIAGEN
- Pacific BioLabs
- InvivoGen
- Microcoat Biotechnologie
- PromoCell GmbH
- Samsung Biologics
- GenScript
- Maravai Lifesciences
- Accugen Laboratories
- Nelson Laboratories
Outline of Major
Chapters:
Chapter 1: Introduces the definition of Biological Safety and Biocompatibility Testing, market overview.
Chapter 2: Global Biological Safety and Biocompatibility Testing market size in revenue and volume.
Chapter 3: Detailed analysis of Biological Safety and Biocompatibility Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biological Safety and Biocompatibility Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biological Safety and Biocompatibility Testing capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
